Celldex Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 8.08 M | $219.44 M | 39.30% | 12.16% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 5.94 M | $161.42 M | -2.58% | 8.95% |
| BLACKROCK, INC. | 02/12/2026 | 5.45 M | $148.07 M | -0.98% | 8.21% |
| FMR LLC | 02/17/2026 | 4.91 M | $133.29 M | -1.10% | 7.39% |
| VANGUARD GROUP INC | 01/29/2026 | 4.03 M | $109.38 M | 1.84% | 6.06% |
| BELLEVUE GROUP AG | 02/17/2026 | 3.62 M | $98.26 M | 1.69% | 5.45% |
| STATE STREET CORP | 02/13/2026 | 3.40 M | $92.28 M | 19.55% | 5.12% |
| COMMODORE CAPITAL LP | 02/17/2026 | 2.57 M | $69.67 M | -15.30% | 3.86% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 2.04 M | $55.40 M | -14.39% | 3.07% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 1.90 M | $51.62 M | -4.96% | 2.86% |
| BRAIDWELL LP | 02/17/2026 | 1.86 M | $50.47 M | 214.03% | 2.80% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 1.76 M | $47.76 M | -54.84% | 2.65% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 1.64 M | $44.61 M | -11.65% | 2.47% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.63 M | $44.21 M | -1.19% | 2.45% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 1.43 M | $38.97 M | 24.33% | 2.16% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.21 M | $32.94 M | 24.36% | 1.83% |
| NOVO HOLDINGS A/S | 02/17/2026 | 1.20 M | $32.59 M | 0.00% | 1.81% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 1.17 M | $31.64 M | -3.32% | 1.75% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.07 M | $29.01 M | 3.76% | 1.61% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 1.01 M | $27.38 M | -22.48% | 1.52% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 968.62 K | $26.31 M | -20.08% | 1.46% |
| FISHER ASSET MANAGEMENT, LLC | 02/09/2026 | 937.16 K | $25.45 M | 1.08% | 1.41% |
| 02/17/2026 | 865.00 K | $23.49 M | 100.00% | 1.30% | |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 855.23 K | $23.23 M | 4.86% | 1.29% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 692.54 K | $18.81 M | -4.02% | 1.04% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 665.37 K | $18.07 M | 0.00% | 1.00% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 651.72 K | $17.70 M | 153.50% | 0.98% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 646.77 K | $17.57 M | 490.97% | 0.97% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 550.73 K | $14.96 M | -0.57% | 0.83% |
| NORTHERN TRUST CORP | 02/17/2026 | 550.00 K | $14.94 M | -7.62% | 0.83% |
| SEGALL BRYANT & HAMILL, LLC | 02/13/2026 | 514.53 K | $13.97 M | -2.66% | 0.77% |
| WOODLINE PARTNERS LP | 02/17/2026 | 500.13 K | $13.58 M | 150.95% | 0.75% |
| 5AM VENTURE MANAGEMENT, LLC | 02/17/2026 | 497.27 K | $13.51 M | 0.00% | 0.75% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 414.89 K | $11.27 M | 22.45% | 0.62% |
| TSP CAPITAL MANAGEMENT GROUP, LLC | 01/21/2026 | 375.13 K | $10.19 M | -0.21% | 0.56% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 350.00 K | $9.51 M | 16.67% | 0.53% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 350.00 K | $9.51 M | 100.00% | 0.53% |
| UBS GROUP AG | 01/29/2026 | 326.46 K | $8.87 M | -21.61% | 0.49% |
| MORGAN STANLEY | 02/13/2026 | 285.54 K | $7.76 M | -8.46% | 0.43% |
| REDMILE GROUP, LLC | 02/17/2026 | 283.31 K | $7.69 M | -13.36% | 0.43% |
| TFG ASSET MANAGEMENT GP LTD | 02/17/2026 | 243.80 K | $6.62 M | -19.70% | 0.37% |
| BARCLAYS PLC | 02/13/2026 | 240.59 K | $6.53 M | -1.73% | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/17/2026 | 239.76 K | $6.51 M | 15.40% | 0.36% |
| CI PRIVATE WEALTH, LLC | 03/09/2026 | 234.70 K | $6.21 M | -2.05% | 0.35% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 230.66 K | $6.26 M | 72.29% | 0.35% |
| NUVEEN, LLC | 02/12/2026 | 200.70 K | $5.45 M | -19.46% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 194.55 K | $5.28 M | -5.42% | 0.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 191.07 K | $5.19 M | -45.24% | 0.29% |
| JPMORGAN CHASE & CO | 02/11/2026 | 173.68 K | $4.72 M | -6.01% | 0.26% |
| MIRADOR CAPITAL PARTNERS LP | 01/14/2026 | 170.66 K | $4.64 M | 2.86% | 0.26% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Celldex Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 247 institutional investors and hedge funds held shares of Celldex Therapeutics Inc.. The most heavily invested institutionals were:
DIMENSIONAL FUND ADVISORS LP: 1.06 M
Fisher Asset Management, LLC: 1.01 M
Pictet Asset Management Holding SA: 923,696
VANGUARD FIDUCIARY TRUST CO: 429,597
TSP Capital Management Group, LLC: 375,127
UBS Group AG: 296,970
110.51% of Celldex Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 82.58 M shares in the last 24 months. This purchase volume represents approximately $2.54 B in transactions.